NCT07671781

Brief Summary

This prospective observational study evaluates intraoperative processed electroencephalography parameters in adult patients undergoing elective rhinoplasty under total intravenous anesthesia with controlled hypotension. The study focuses on qCON and qNOX values during anesthesia, their relationship with early postoperative recovery, and their association with intraoperative surgical bleeding and surgical field quality.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
64

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Nov 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2025

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 25, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 25, 2026

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

June 20, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 26, 2026

Completed
Last Updated

June 26, 2026

Status Verified

February 1, 2026

Enrollment Period

4 months

First QC Date

June 20, 2026

Last Update Submit

June 25, 2026

Conditions

Keywords

processed EEGqCON, qNOXrhinoplastyesmololTIVArecovery qualitycontrolled hypotension

Outcome Measures

Primary Outcomes (1)

  • Intraoperative qCON and qNOX values during controlled hypotension

    qCON and qNOX values obtained by processed EEG monitoring will be recorded at predefined intraoperative time points. qCON will be used as an index of hypnotic depth, and qNOX will be used as an index of the probability of response to nociceptive stimulation.

    From baseline before anesthesia induction until the end of surgery, up to approximately 150 minutes intraoperatively.

Secondary Outcomes (1)

  • Heart rate during controlled hypotension

    From baseline before anesthesia induction until the end of surgery, up to approximately 150 minutes intraoperatively.

Other Outcomes (5)

  • Surgical field bleeding score

    Intraoperatively, from surgical incision until the end of surgery.

  • Extubation time

    At the end of surgery

  • Time to reach Aldrete score ≥9

    Early postoperative recovery period, immediately after extubation.

  • +2 more other outcomes

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients scheduled for elective rhinoplasty under general anesthesia at Gazi University Faculty of Medicine were included in this prospective observational study. All patients underwent total intravenous anesthesia with esmolol-supported controlled hypotension and intraoperative processed EEG monitoring. Hemodynamic parameters, qCON and qNOX values, surgical bleeding scores, anesthetic drug consumption, and early postoperative recovery outcomes were recorded.

You may qualify if:

  • Patients aged 18 years or older
  • Patients scheduled for elective rhinoplasty
  • Patients classified as ASA physical status I-II
  • Patients planned to undergo general anesthesia with total intravenous anesthesia
  • Patients in whom frontal processed EEG electrodes can be applied
  • Patients who provide written informed consent

You may not qualify if:

  • Emergency surgery
  • Severe neurological disease
  • Scalp lesion or marked dermatitis preventing processed EEG electrode placement
  • Communication or hearing impairment preventing postoperative assessment
  • Marked hemodynamic instability
  • Multiple trauma or need for postoperative intensive care unit admission
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gazi University

Ankara, Turkey (Türkiye)

Location

Related Publications (3)

  • Laferriere-Langlois P, Morisson L, Jeffries S, Duclos C, Espitalier F, Richebe P. Depth of Anesthesia and Nociception Monitoring: Current State and Vision For 2050. Anesth Analg. 2024 Feb 1;138(2):295-307. doi: 10.1213/ANE.0000000000006860. Epub 2024 Jan 12.

    PMID: 38215709BACKGROUND
  • Kol IO, Kaygusuz K, Yildirim A, Dogan M, Gursoy S, Yucel E, Mimaroglu C. Controlled hypotension with desflurane combined with esmolol or dexmedetomidine during tympanoplasty in adults: A double-blind, randomized, controlled trial. Curr Ther Res Clin Exp. 2009 Jun;70(3):197-208. doi: 10.1016/j.curtheres.2009.06.001.

    PMID: 24683230BACKGROUND
  • Aldecoa C, Bettelli G, Bilotta F, Sanders RD, Aceto P, Audisio R, Cherubini A, Cunningham C, Dabrowski W, Forookhi A, Gitti N, Immonen K, Kehlet H, Koch S, Kotfis K, Latronico N, MacLullich AMJ, Mevorach L, Mueller A, Neuner B, Piva S, Radtke F, Blaser AR, Renzi S, Romagnoli S, Schubert M, Slooter AJC, Tommasino C, Vasiljewa L, Weiss B, Yuerek F, Spies CD. Update of the European Society of Anaesthesiology and Intensive Care Medicine evidence-based and consensus-based guideline on postoperative delirium in adult patients. Eur J Anaesthesiol. 2024 Feb 1;41(2):81-108. doi: 10.1097/EJA.0000000000001876. Epub 2023 Aug 30.

    PMID: 37599617BACKGROUND

Study Officials

  • Nurdan Bedirli, MD

    Gazi University

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principal investigator

Study Record Dates

First Submitted

June 20, 2026

First Posted

June 26, 2026

Study Start

November 1, 2025

Primary Completion

February 25, 2026

Study Completion

February 25, 2026

Last Updated

June 26, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared due to institutional and ethical restrictions and to protect participant confidentiality.

Locations